Lenox Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$23K Sell
98
-493
-83% -$112K 0.01% 337
2020
Q1
$119K Buy
591
+134
+29% +$29.3K 0.04% 177
2019
Q4
$110K Buy
457
+48
+12% +$10.6K 0.03% 203
2019
Q3
$79K Buy
409
+87
+27% +$16.7K 0.02% 229
2019
Q2
$59K Buy
322
+124
+63% +$22.2K 0.02% 234
2019
Q1
$38K Buy
198
+52
+36% +$9.93K 0.01% 265
2018
Q4
$28K Buy
146
+24
+20% +$4.68K 0.01% 250
2018
Q3
$25K Sell
122
-9
-7% -$1.77K 0.01% 289
2018
Q2
$24K Sell
131
-93
-42% -$16.4K 0.01% 270
2018
Q1
$38K Buy
224
+89
+66% +$16.3K 0.01% 238
2017
Q4
$23K Sell
135
-80
-37% -$14.2K 0.01% 292
2017
Q3
$40K Buy
+215
New +$38.1K 0.01% 247

Other funds holding AMGN

Lenox Wealth Management's AMGN Position: Q2 2020 in Review

Lenox Wealth Management reduced its Amgen (AMGN) stake by 83% in Q2 2020, selling an estimated $112K and leaving 98 shares worth $23K. The position accounts for 0.01% of the portfolio, ranked #337.

Lenox Wealth Management first reported a position in AMGN in Q3 2017 and has held it in 12 quarters since. The position peaked at $119K in Q1 2020. 2,090 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • Lenox Wealth Management held 98 shares of Amgen worth $23K as of Q2 2020.
  • Lenox Wealth Management sold 493 Amgen shares in Q2 2020, an estimated $112K.
  • Amgen made up 0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #337 holding.
  • Lenox Wealth Management first reported a position in Amgen in Q3 2017 and has held it in 12 quarters since.
  • Lenox Wealth Management's Amgen position peaked at $119K in Q1 2020.
  • 2,090 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.